Quanterix Corporation QTRX
1.96 USD -0.07 (-3.45%)
Regular-session close
1.96 0.00 0.00%
After hours · Nov 20, 4:26 PM ET
1.78 Day range 2.03
1.77 52-week range 8.77
- YTD
- -69.18%
- 1 year
- -66.84%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Akanda (NASDAQ:AKAN) shares rose 66.8% to $3.42 during Wednesday's regular session. The market value of their outstanding shares is at $5.4 million. Cue Biopharma (NASDAQ:CUE) shares rose…benzinga.com Quanterix Affirms FY2026 Sales Guidance of $142.000M-$146.000M vs $143.357M Est Quanterix (NASDAQ:QTRX) affirms FY2026 sales outlook from $142.000 million-$146.000 million to $142.000 million-$146.000 million vs $143.357 million estimate.
businesswire.com Quanterix Announces Leadership Transition Plan BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a global leader in precision biomarker science, today announced that Everett Cunningham has…
businesswire.com Quanterix Expands Access to Blood-Based Alzheimer's Testing in New Jersey and Surrounding Area Through Exclusive Partnership with Sherman Abrams Laboratory BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX) today announced an exclusive distribution agreement with Sherman Abrams Laboratory, a Brooklyn-based clinical and anatomic…benzinga.com Quanterix Signs MoU With ALZAI Health To Explore Collaboration On Earlier Identification And Assessment Of Alzheimer's The proposed collaboration is intended to explore opportunities to combine ALZAI's AI-driven Alzheimer's disease risk identification technology with Quanterix's LucentAD® blood-based biomarkers, with…
newsfilecorp.com ALZAI Health Corp. Enters into MOU with Quanterix Corporation to Advance Early Alzheimer's Disease Identification Toronto, Ontario--(Newsfile Corp. - November 13, 2026) - ALZAI Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial…benzinga.com TD Cowen Maintains Hold on Quanterix, Raises Price Target to $4 TD Cowen analyst Dan Brennan maintains Quanterix (NASDAQ:QTRX) with a Hold and raises the price target from $3.5 to $4.
benzinga.com Quanterix Q3 2026 Earnings Call Transcript Quanterix (NASDAQ:QTRX) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…benzinga.com Quanterix Q3 EPS $(0.46) Misses $(0.43) Estimate, Sales $34.974M Beat $33.853M Estimate Quanterix (NASDAQ:QTRX) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.43) by 6.98 percent. This is a 36.99 percent increase over losses of $(0.73)…
benzinga.com Quanterix Narrows FY2026 Sales Guidance from $142.000M-$148.000M to $142.000M-$146.000M vs $143.357M Est Quanterix (NASDAQ:QTRX) narrows FY2026 sales outlook from $142.000 million-$148.000 million to $142.000 million-$146.000 million vs $143.357 million estimate.
